International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2024 Oct;34(10):1659. doi: 10.1136/ijgc-2024-005958 Q14.52024

Correspondence on 'Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial' by Bogani et al

Bogani等关于“基于组织学和分子特征预测子宫内膜癌淋巴结病变风险：前瞻性PROME试验”的来信 correspondence regarding 'predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial' by bogani et al 翻译改进

Ana Luzarraga Aznar¹, Vicente Bebia², Silvia Cabrera³

作者单位 +展开

作者单位

¹ Gynecologic Oncology Unit, Gynecology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain. Electronic address: aluzarraga7@gmail.com.

² Gynecologic Oncology Unit, Gynecology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

³ Gynecologic Oncology Unit, Obstetrics and Gynecology Department, Hospital de la Santa Creu i Sant Pau Servei d'Obstetricia i Ginecologia, Barcelona, Spain; Obstetrics and Gynecology Department, Hospital Universitari General de Catalunya, Barcelona, Catalunya, Spain.

DOI: 10.1136/ijgc-2024-005958 PMID: 40229121

摘要中英对照阅读

Keywords：endometrial cancer; nodal disease; molecular features

关键词：子宫内膜癌; 淋巴结病变; 分子特征

收藏本文留言帮助扫码分享

相关内容

期刊名：International journal of gynecological cancer

缩写：INT J GYNECOL CANCER

ISSN：1048-891X

e-ISSN：1525-1438

IF/分区：4.5/Q1

文章目录更多期刊信息

全文链接

官方链接

PMC全文

引文链接

复制

已复制！

格式：

Correspondence on 'Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial' by Bogani et al

Response to: Correspondence on 'Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial' by Aznar et al

Aznar等关于“基于组织学和分子特征预测子宫内膜癌淋巴结病风险：前瞻性PROME试验”的来信回复

Correspondence on 'Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial' by Bogani et al

Bogani等关于“基于组织病理及分子特征预测子宫内膜癌淋巴结转移风险：前瞻性PROME试验”的来信回复

Low-volume metastatic nodal disease in endometrial cancer

子宫内膜癌低容积转移淋巴结病

Comparison of cytogenetic and molecular features observed in endometrial cancers: known clinic and difficulties in treatment

子宫内膜癌的细胞遗传学和分子特征比较：已知的临床问题及其治疗难点

Integration of Clinical and Molecular Features into Prediction Models for Outcomes in Endometrial Cancer

整合临床和分子特征用于子宫内膜癌预后的预测模型

Endometrioid carcinoma of the endometrium: pathologic and molecular features

子宫内膜内膜样癌的病理和分子特征

Tumor Molecular Features Predict Endometrial Cancer Patients' Survival After Open or Minimally Invasive Surgeries

肿瘤分子特征可预测开腹或微创手术后子宫内膜癌患者的生存率

Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial

基于临床、病理及分子特征预测子宫内膜癌盆腔淋巴结转移的前瞻性多中心研究-PROME试验

Nodal disease in temporal bone squamous carcinoma

颞骨鳞癌的淋巴结病